Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens

Area of Science:

• Immunology
• Oral Biology
• Cellular Immunology

Background:

• Langerhans cells (LC) are key antigen-presenting cells in the skin and oral mucosa.
• The functional role of MHC Class II antigens on gingival LC in immune responses remains unclear.
• Dental plaque accumulation can trigger inflammatory responses in the gingiva.

Purpose of the Study:

• To investigate the functional significance of MHC Class II antigens (HLA-DR, -DQ, -DP) on gingival Langerhans cells.
• To determine the role of these antigens in alloantigen presentation by gingival LC.
• To understand the initiation of cellular immune responses to dental plaque.

Main Methods:

• Utilized the mixed epithelial cell-lymphocyte culture reaction (MECLR) as an in vitro model.
• Prepared epithelial cell suspensions from human gingiva.
• Employed monoclonal antibodies (L243, B7/21, SK10) targeting MHC Class II antigens and complement for cell depletion and pre-treatment.

Main Results:

• MHC Class II antigen expression (HLA-DR, -DP, -DQ) was exclusively found on CD1a-positive LC in gingival epithelium.
• Depletion or pre-treatment of gingival LC with MHC Class II-specific antibodies significantly inhibited lymphocyte proliferation in the MECLR.
• These findings demonstrate the involvement of HLA-DQ and -DP, along with DR, in LC-lymphocyte interactions.

Conclusions:

• Gingival Langerhans cells present antigens via MHC Class II molecules (HLA-DR, -DQ, -DP).
• These molecules are essential for LC-lymphocyte interactions and the initiation of cellular immune responses.
• Alterations in MHC Class II expression on gingival LC can impact immune responses to dental plaque accumulation.